To amend title III of the Public Health Service Act to terminate the effective time period for immunity for manufacturers of COVID-19 vaccines, and for other purposes.
USA117th CongressHR-6106| House
| Updated: 12/2/2021
Lance Gooden
Republican Representative
Texas
Cosponsors (1)
Health Subcommittee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
This bill terminates on December 1, 2021, certain protections from liability that apply to manufacturers of COVID-19 vaccines. Currently, the liability protections generally expire on October 1, 2024, unless the underlying declaration of emergency is rescinded earlier.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Health
Cardiovascular and respiratory healthCivil actions and liabilityDrug safety, medical device, and laboratory regulationEmergency medical services and trauma careImmunology and vaccinationInfectious and parasitic diseasesManufacturing
To amend title III of the Public Health Service Act to terminate the effective time period for immunity for manufacturers of COVID-19 vaccines, and for other purposes.
USA117th CongressHR-6106| House
| Updated: 12/2/2021
This bill terminates on December 1, 2021, certain protections from liability that apply to manufacturers of COVID-19 vaccines. Currently, the liability protections generally expire on October 1, 2024, unless the underlying declaration of emergency is rescinded earlier.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Lance Gooden
Republican Representative
Texas
Cosponsors (1)
Health Subcommittee, Energy and Commerce Committee
Health
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Cardiovascular and respiratory healthCivil actions and liabilityDrug safety, medical device, and laboratory regulationEmergency medical services and trauma careImmunology and vaccinationInfectious and parasitic diseasesManufacturing